Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient

Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Lymphoma Myeloma and Leukemia - Volume 14, Issue 4, August 2014, Pages e119-e122

Alessandro Broccoli, Cinzia Pellegrini, Monica Celli, Lisa Argnani, Claudio Agostinelli, Stefano Pileri, Pier Luigi Zinzani,